TTNP - Titan Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.45M
Enterprise Value 318.72M
Trailing P/E N/A
Forward P/E 1-4.65
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.99
Price/Book (mrq)6.23
Enterprise Value/Revenue 32.88
Enterprise Value/EBITDA 6-1.91

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -168.26%
Operating Margin (ttm)-156.05%

Management Effectiveness

Return on Assets (ttm)-75.78%
Return on Equity (ttm)-990.04%

Income Statement

Revenue (ttm)6.5M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)-11.20%
Gross Profit (ttm)-1.4M
EBITDA -9.81M
Net Income Avi to Common (ttm)-11.22M
Diluted EPS (ttm)-0.7870
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.91M
Total Cash Per Share (mrq)0.45
Total Debt (mrq)5.07M
Total Debt/Equity (mrq)165.93
Current Ratio (mrq)2.12
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-11.74M
Levered Free Cash Flow (ttm)-7.76M

Trading Information

Stock Price History

Beta (3Y Monthly) -0.11
52-Week Change 3-69.21%
S&P500 52-Week Change 34.96%
52 Week High 36.9000
52 Week Low 31.0320
50-Day Moving Average 31.6525
200-Day Moving Average 31.7157

Share Statistics

Avg Vol (3 month) 3818.58k
Avg Vol (10 day) 3398.12k
Shares Outstanding 513.51M
Float 12.65M
% Held by Insiders 14.32%
% Held by Institutions 14.99%
Shares Short (Apr 30, 2019) 41.18M
Short Ratio (Apr 30, 2019) 42.41
Short % of Float (Apr 30, 2019) 49.10%
Short % of Shares Outstanding (Apr 30, 2019) 48.77%
Shares Short (prior month Mar 29, 2019) 41.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Sep 29, 2015